Exploration of breath analysis to monitor therapeutic response in mesothelioma patients

E. Janssens (Antwerp, Belgium), J. Van Meerbeeck (Antwerp, Belgium), K. Lamote (Antwerp, Belgium)

Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding
Session: Brain Metastasis and Malignant pleural effusion: improving our understanding
Session type: Oral Presentation
Number: 3797
Disease area: Thoracic oncology

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Janssens (Antwerp, Belgium), J. Van Meerbeeck (Antwerp, Belgium), K. Lamote (Antwerp, Belgium). Exploration of breath analysis to monitor therapeutic response in mesothelioma patients. 3797

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Breath analysis allows to predict treatment response in malignant pleural mesothelioma patients.
Source: Virtual Congress 2021 – Novel insights into the diagnosis, mechanism and treatment of malignant pleural disease
Year: 2021



Exhaled breath analysis allows exclusive screening for malignant pleural mesothelioma.
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017

Chemical characterization of exhaled breath to discriminate patients with malignant pleural mesothelioma from subjects with similar professional asbestos exposure
Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Year: 2010


Early detection of lung cancer through analysis of VOC biomarkers in exhaled breath: The LuCID study.
Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies
Year: 2017

Exhaled breath to screen for malignant pleural mesothelioma: a validation study
Source: Eur Respir J, 50 (6) 1700919; 10.1183/13993003.00919-2017
Year: 2017



Evaluation of chemotherapy response determined by volumetric method in malignant pleural mesothelioma and its effect on determination to survival
Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Year: 2018

Clinical usefulness of the novel drug sensitivity test for malignancy using pleural effusion
Source: Annual Congress 2006 - Lung cancer biology and chemosensitivity
Year: 2006


A combinational approach to optimize biomarkers efficacy in identifying patients with sarcoidosis and monitoring respiratory functional worsening
Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV
Year: 2012

Evaluation of breath sampling procedures in lung cancer patients
Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology
Year: 2008

Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease
Source: Eur Respir J, 57 (1) 2002042; 10.1183/13993003.02042-2020
Year: 2021



Reliability of computer aided lung sound analysis detecting crackles in bronchiectasis patients – a potential outcome measure for respiratory physiotherapy
Source: Annual Congress 2008 - Mucociliary clearance, novel techniques and assessments, in adult, paediatric and mechanically ventilated patients
Year: 2008


Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma?
Source: Eur Respir J 2011; 37: 162-168
Year: 2011



Evaluation of response to chemotherapy for malignant pleural mesothelioma and suggestion of a new method
Source: Eur Respir J 2002; 20: Suppl. 38, 272s
Year: 2002

A novel proteomic technique to identify new diagnostic biomarkers for malignant pleural mesothelioma: a feasibility study.
Source: Virtual Congress 2021 – Novel insights into the diagnosis, mechanism and treatment of malignant pleural disease
Year: 2021



Combining exhaled-breath analysis data with clinical parameters to improve the diagnosis of lung cancer
Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Year: 2019

The impact of multimodal treatment approaches in patients with malignant pleural mesothelioma
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010


Multiple breath washout technique is a helpful clinical tool for assessing respiratory disease - pro
Source: International Congress 2018 – Current and evolving tests in lung function: pro/con debate
Year: 2018


Identification of predictive biomarkers of immunotherapy response in non-small cell lung cancer by multiparametric analysis
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Year: 2021



Back to the future: integrating breath analysis in lung function equipment
Source: International Congress 2015 – The next generation of lung function tests
Year: 2015



Is the analysis of torbamycin in exhaled breath condensate a diagnostic tool to monitor pulmonary drug deposition?
Source: Eur Respir J 2004; 24: Suppl. 48, 386s
Year: 2004